4 completed. 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 4 | Completed 4 |
Follow Alefacept: new trials by email Literature Review of Alefacept trials Research Report on Alefacept
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Assess the Efficacy and Safety of Alefacept in Psoriasis Patients for Whom Conventional Treatment is Ineffective or Inappropriate alefacept, placebo - Chronic Plaque Psoriasis | Phase 3 | Completed | Astellas Pharma Inc | 195 | 2003-10-01 | 2014-08-26 |
| A Study to Assess the Efficacy and Safety of Two Dosing Regimens of Alefacept in Subjects Weighing Between 100kg and 150kg With Moderate to Severe Chronic Plaque Psoriasis alefacept - Chronic Plaque Psoriasis | Phase 3 | Completed | Astellas Pharma Inc | 78 | 2003-07-01 | 2014-08-26 |
| Safety and Tolerability of Repeat Courses of IM Alefacept Alefacept - Chronic Plaque Psoriasis | Phase 3 | Completed | Biogen | 400 | 2002-12-01 | 2023-08-23 |
| Open-label Study to Evaluate Safety of Multiple Courses of IM Alefacept During Treatment of Chronic Plaque Psoriasis Alefacept - Psoriasis | Phase 3 | Completed | Astellas Pharma Inc | 175 | 2001-12-01 | 2014-09-18 |
Psoriasis (1)
Astellas Pharma Inc (3) · Biogen (1)
Canada (4) · United States (4) · Germany (3) · Austria (2) · Belgium (2) · Denmark (2) · France (2) · Netherlands (2) · United Kingdom (2) · Spain (1) · Switzerland (1)
Barry Ticho, MD (1) · Kenneth Gordon, MD (1)